Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment Original Post PRINCETON, N.J.–(BUSINESS WIRE)–Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001,...
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc. Initial Equity Financing Supplements Grant Awards Received by Lactiga PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) — Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company...
Original Post PRINCETON, N.J.--(BUSINESS WIRE)--Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration agreement ...
